Low Birth Weight Follow-up
NCT03020147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1258
Last updated 2021-04-26
Summary
The Randomized Control Trail included 4,172 low-birth weight children between February 2008 and September 2013 in Bissau. The children who were included in the RCT and who are living in the Bandim Health Project study area will be visited. The study assistants will ask about the health of the child and of both parents. Furthermore, Bacille Calmette-Guerin (BCG) scar status of both child and parents will be checked.
Conditions
- Non Specific Effects of Vaccine
- Bacillus-Calmette-Guerin
- Low Birth Weight
- Maternal Immunisation
Sponsors & Collaborators
-
Bandim Health Project
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-15
- Primary Completion
- 2017-12-15
- Completion
- 2021-01-15
Countries
- Guinea-Bissau
Study Locations
More Related Trials
-
Trial to Compare BCG-Bulgaria and BCG-Denmark
NCT05397678 ·Status: RECRUITING ·Phase: PHASE4
-
BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa
NCT07005726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Randomized Trial of Providing BCG Vaccination Immediately
NCT01989026 ·Status: TERMINATED ·Phase: PHASE4
-
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
NCT01420705 ·Status: COMPLETED
-
Trial of Two Strains of BCG
NCT02447536 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Morbidity and Mortality Effects of Two Different Strains of BCG
NCT03400878 ·Status: COMPLETED ·Phase: PHASE4
-
BCG Vaccination Scar Formation in Children Under Five Years :Factors Affecting Its Formation and Subsequent Adverse Effects .
NCT03548233 ·Status: UNKNOWN ·Phase: NA
-
Trial to Compare Two Strains of BCG
NCT04383925 ·Status: COMPLETED ·Phase: PHASE4
-
Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
NCT01694108 ·Status: COMPLETED ·Phase: PHASE4
-
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
NCT05180591 ·Status: RECRUITING ·Phase: PHASE2
-
Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
NCT04152161 ·Status: TERMINATED ·Phase: PHASE2
-
Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau
NCT02953327 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
NCT02444611 ·Status: COMPLETED ·Phase: NA
-
Measles and BCG Vaccines for Mother and Child
NCT04899765 ·Status: RECRUITING ·Phase: PHASE4
-
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
NCT05866536 ·Status: RECRUITING ·Phase: PHASE2
-
Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates
NCT03536117 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.
NCT00242047 ·Status: UNKNOWN ·Phase: PHASE4
-
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04641858 ·Status: COMPLETED ·Phase: PHASE4
-
BCG Revaccination in Children and Adolescents
NCT05330884 ·Status: SUSPENDED ·Phase: PHASE3
-
Non-specific Effects of BCG in Under-five Children
NCT05471167 ·Status: UNKNOWN
-
BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)
NCT04534803 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in Infants
NCT04351685 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa
NCT02391415 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
NCT02378207 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa
NCT01479972 ·Status: COMPLETED ·Phase: PHASE2